Context A substantial proportion of people at clinical high risk of psychosis will develop a
psychotic disorder over time. However, the risk of transition to psychosis varies between …

Importance Estimating the current likelihood of transitioning from a clinical high risk for
psychosis (CHR-P) to psychosis holds paramount importance for preventive care and …

Diagnosis of a clinical high-risk (CHR) state enables timely treatment of individuals at risk for
a psychotic disorder, thereby contributing to improving illness outcomes. However, only a …

Recent evidence suggests that transition risks from initial clinical high risk (CHR) status to
psychosis are decreasing. The role played by remission in this context is mostly unknown …

Aims The clinical outcomes of individuals at clinical high risk of psychosis (CHR-P) who do
not transition to psychosis are heterogeneous and inconsistently reported. We aimed to …

Twenty percent of individuals at clinical high risk for psychosis (CHR-P) develop the disorder
within 2 years. Extensive research has explored the factors that differentiate those who …

BackgroundTo enhance indicated prevention in patients with a clinical high risk (CHR) for
psychosis, recent research efforts have been increasingly directed towards estimating the …

Objective: A major focus of early intervention research is determining the risk of conversion
to psychosis and developing optimal algorithms of prediction. Although reported rates of …

OBJECTIVE: We examined if age of onset of psychiatric symptoms and/or sex predict
conversion to non-affective or affective psychosis in individuals considered to be at ultra …

Recently developed criteria have been successful at identifying individuals at imminent risk
of developing a psychotic disorder, but these criteria lead to 50–60% false positives. This …